TY - CHAP
T1 - The Newly Proposed Lung Cancer TNM Classification
T2 - Review and Clinical Implications
AU - Casal, Roberto F.
AU - Morice, Rodolfo F.
N1 - Publisher Copyright:
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2013, 2018, 2023.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Lung cancer remains the number one cause of cancer-related mortality in the Western World, with more than 1,000,000 deaths each year (Parkin et al., CA Cancer J Clin 55:74–108, 2002). Staging is vital in the approach to lung cancer since it offers both prognostic information and a guide for treatment decisions. A unified and universally accepted staging system is also essential to standardize nomenclature for international comparisons of clinical trials. The TNM system provides a detailed description of cancers based on the extent of the anatomic involvement, by defining the primary tumor (T), the regional lymph node involvement (N), and the presence of distant metastases (M) (Lababede et al., Chest 139(1):183–189, 2011). In this chapter we will review the proposed changes for the eighth edition of the International Association for the Study of Lung Cancer (IASLC) TNM staging system, and we will discuss its clinical implications, strengths, and limitations.
AB - Lung cancer remains the number one cause of cancer-related mortality in the Western World, with more than 1,000,000 deaths each year (Parkin et al., CA Cancer J Clin 55:74–108, 2002). Staging is vital in the approach to lung cancer since it offers both prognostic information and a guide for treatment decisions. A unified and universally accepted staging system is also essential to standardize nomenclature for international comparisons of clinical trials. The TNM system provides a detailed description of cancers based on the extent of the anatomic involvement, by defining the primary tumor (T), the regional lymph node involvement (N), and the presence of distant metastases (M) (Lababede et al., Chest 139(1):183–189, 2011). In this chapter we will review the proposed changes for the eighth edition of the International Association for the Study of Lung Cancer (IASLC) TNM staging system, and we will discuss its clinical implications, strengths, and limitations.
UR - http://www.scopus.com/inward/record.url?scp=85206132662&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85206132662&partnerID=8YFLogxK
U2 - 10.1007/9783031226106_19
DO - 10.1007/9783031226106_19
M3 - Chapter
AN - SCOPUS:85206132662
SN - 9783031226090
SP - 327
EP - 338
BT - Interventions in Pulmonary Medicine, Third Edition
PB - Springer International Publishing
ER -